Biological Pathways Associated with Neuroprogression in Bipolar Disorder
There is evidence suggesting clinical progression in a subset of patients with bipolar disorder (BD). This progression is associated with worse clinical outcomes and biological changes. Molecular pathways and biological markers of clinical progression have been identified and may explain the progres...
Main Authors: | Bianca Wollenhaupt-Aguiar, Flavio Kapczinski, Bianca Pfaffenseller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/11/2/228 |
Similar Items
-
Staging and neuroprogression in bipolar disorder: a systematic review of the literature
by: Clarissa Severino Gama, et al.
Published: (2013-03-01) -
Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature
by: Gianluca Serafini, et al.
Published: (2021-02-01) -
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
by: Cynthia Calkin, et al.
Published: (2021-05-01) -
Neuroprogression: the hidden mechanism of depression
by: Labra Ruiz NA, et al.
Published: (2018-10-01) -
Awaiting accurate scientific evidence: Progression or “profiles” in bipolar disorder?
by: Diego J. Martino, et al.
Published: (2017-05-01)